Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland

About this trial

This study is to evaluate the sensitivity and intra-/inter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.

Eligibility criteria

Qualifiers

Diagnosis of multiple sclerosis according to established international criteria

Steroid free period: > 4 weeks

Participation in the Swiss MS Cohort (SMSC) study

Disqualifiers

. History of severe (other) neurological, internal or psychiatric disease with SC affection

Paramagnetic and/or superparamagnetic foreign objects in the body (especially when located close to the SC)

Pacemaker

Claustrophobia

Trial design

Treatments tested in this trial

  • SC MRI
  • patient questionnaire

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Basel, Switzerland

Lead sponsor

Freie Akademische Gesellschaft Basel

Collaborator